focus -WSS

focus

author：leisure time 2025-10-01 12:35:11 - browse：4

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Medical experts are missing from AI regulatory conversations

hotspot

WSS

Biden tests positive for Covid

Sanders adds drug shortage policies to pandemic preparedness bill

Sanders adds drug shortage policies to pandemic preparedness bill

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Couple fighting to bring baby home from Mexico are finally reunited

Medicare to cover more brain scans for Alzheimer’s patients

entertainment

focus

hotspot

In Memoriam: Notable people who died in 2023

Custom gene therapy hints at new path for rare disease treatments

Novavax promises a turnaround & Lilly roils the obesity market

DOJ, FTC to increase scrutiny of all types of health care mergers

New air purifier tech could be key to improving indoor air quality

Google and Epic fight stronger regulation of AI in health care

How to save PrEP access — and even expand it

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Heart attack and stroke risk calculators need revising

Resistance to cancer drugs: A new genetic explanation

hotspot

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

DOJ, FTC to increase scrutiny of all types of health care mergers

Listen: Wegovy in the brain & pivotal Alzheimer's data

Stanford updates investigation of president’s past research

Stanford updates investigation of president’s past research

Listen: Wegovy in the brain & pivotal Alzheimer's data

knowledge

hotspot

hotspot

hotspot